ChemoCentryx obtains United States patent.

ChemoCentryx, Inc. (Mountain View, CA) has patented polypeptides and polynucleotides encoding a novel chemokine receptor, CCX CKR. The invention further provides reagents and methods for identifying agents that modulate the activity or expression of the receptors, as well as methods for detecting receptor expression. (US 7,108,990)